Furthermore, the mutation of AKAP9 was associated with poor prognosis outcomes of ESCC patients (log-rank test, p = 0.029) indicating the potential functions of AKAP9 mutation in ESCC progression (Supplementary Fig. 6j). Here, AKAP9 is linked to esophageal squamous cell carcinoma.